Study of lipid profile in streptozotocin (stz) – induced diabetic rats under nicotinamide coverage treated with ocimum gratissimum (o.g.) and vernonia amygdalina (v.a.)

Chapter ONE

INTRODUCTION

• 1.1Introduction
• 1.2Background of Study
• 1.3Problem Statement
• 1.4Objective of Study
• 1.5Limitation of Study
• 1.6Scope of Study
• 1.7Significance of Study
• 1.8Structure of the Research
• 1.9Definition of Terms

Chapter TWO

LITERATURE REVIEW

• 2.1Lipid Profile Overview
• 2.2Diabetes Mellitus and Lipid Profile
• 2.3Streptozotocin (STZ) Induced Diabetes
• 2.4Nicotinamide Coverage in Diabetes Treatment
• 2.5Ocimum Gratissimum (O.G.) in Diabetes Management
• 2.6Vernonia Amygdalina (V.A.) in Diabetes Management
• 2.7Experimental Studies on Lipid Profile
• 2.8Effects of Medicinal Plants on Lipid Profile
• 2.9Role of Diet in Lipid Profile Management
• 2.10Current Research Trends in Lipid Profile Studies

Chapter THREE

RESEARCH METHODOLOGY

• 3.1Research Methodology Overview
• 3.2Research Design and Approach
• 3.3Selection of Sample Population
• 3.4Data Collection Methods
• 3.5Data Analysis Techniques
• 3.6Ethical Considerations
• 3.7Reliability and Validity of Data
• 3.8Limitations of the Research Methodology

Chapter FOUR

DATA PRESENTATION AND ANALYSIS

• 4.1Analysis of Lipid Profile Data
• 4.2Impact of STZ Induction on Lipid Profile
• 4.3Effects of Nicotinamide Coverage on Lipid Profile
• 4.4Evaluation of O.G. Treatment on Lipid Profile
• 4.5Assessment of V.A. Treatment on Lipid Profile
• 4.6Comparison of Medicinal Plants' Effects on Lipid Profile
• 4.7Discussion on Lipid Profile Changes
• 4.8Implications for Diabetes Management

Chapter FIVE

SUMMARY, CONCLUSION AND RECOMMENDATIONS

• 5.1Conclusion and Summary
• 5.2Recap of Research Objectives
• 5.3Key Findings Overview
• 5.4Contributions to Existing Knowledge
• 5.5Practical Implications
• 5.6Recommendations for Future Research